OKYO Pharma Limited Sponsored ADR's total assets for Q2 2023 were £1.59M, a decrease of -63.05% from the previous quarter. OKYO total liabilities were £1.90M for the fiscal quarter, a 40.31% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.